MLL-EVs increased G tumor cell viability over time, in a dose-dependent manner, compared to G-EVs and PBS, suggesting that the MLL-EVs also could have direct effects on tumor cell growth (Fig. 5). This evidence concerns the gene KMT2A and neoplasm.